Literature DB >> 5938421

Mechanism of a reaction in vitro associated with delayed-type hypersensitivity.

B R Bloom, B Bennett.   

Abstract

The cell type responsible for inhibition by antigen of migration in vitro of peritoneal exudate cells obtained from tuberculin-hypersensitive guinea pigs was studied. Exudate populations were separated into component cell types, the lymphocyte and the macrophage. Peritoneal lymphocytes from sensitive donors were the immunologically active cells in this system, the macrophages, being merely indicator cells which migrate. Sensitized peritoneal lymphocyte populations, upon interaction with specific antigen in vitro, elaborated into the medium a soluble material capable of inhibiting migration of normal exudate cells.

Entities:  

Mesh:

Substances:

Year:  1966        PMID: 5938421     DOI: 10.1126/science.153.3731.80

Source DB:  PubMed          Journal:  Science        ISSN: 0036-8075            Impact factor:   47.728


  420 in total

1.  Host defence mechanisms.

Authors:  L S Salimonu
Journal:  Indian J Pediatr       Date:  1976-02       Impact factor: 1.967

Review 2.  Cytokines: past, present, and future.

Authors:  J J Oppenheim
Journal:  Int J Hematol       Date:  2001-07       Impact factor: 2.490

3.  Mediation of macrophage effector function by lymphokine.

Authors:  L W Poulter; J L Turk
Journal:  Agents Actions       Date:  1976-02

4.  Clinicopathological significance of macrophage migration inhibitory factor and its relation with p53 in gastric cancer.

Authors:  Majid Nabizadeh Marvast; Hamid Reza Sima; Kamran Ghaffarzadehgan; Ali Taghizadeh Kermani; Nona Norouzi
Journal:  J Gastrointest Cancer       Date:  2011-03

5.  Macrophage migration inhibitory factor levels in the vitreous of patients with proliferative diabetic retinopathy.

Authors:  Y Mitamura; S Takeuchi; A Matsuda; Y Tagawa; Y Mizue; J Nishihira
Journal:  Br J Ophthalmol       Date:  2000-06       Impact factor: 4.638

6.  Allosteric inhibition of macrophage migration inhibitory factor revealed by ibudilast.

Authors:  Yoonsang Cho; Gregg V Crichlow; Jon J Vermeire; Lin Leng; Xin Du; Michael E Hodsdon; Richard Bucala; Michael Cappello; Matt Gross; Federico Gaeta; Kirk Johnson; Elias J Lolis
Journal:  Proc Natl Acad Sci U S A       Date:  2010-06-08       Impact factor: 11.205

7.  Increase of macrophage migration inhibitory factor in sera of patients with iridocyclitis.

Authors:  N Kitaichi; S Kotake; Y Mizue; H Matsuda; K Onoé; J Nishihira
Journal:  Br J Ophthalmol       Date:  2000-12       Impact factor: 4.638

8.  Association of the macrophage migration inhibitory factor promoter polymorphisms with benign lymphoepithelial lesion of lacrimal gland.

Authors:  Qin-Jian Li; Peng-Xiang Zhao; Xu-Juan Zhang; Yang Yi; Dan-Ying Cheng; Jian-Min Ma; Xue-Mei Ma
Journal:  Int J Ophthalmol       Date:  2017-08-18       Impact factor: 1.779

9.  Molecular cloning of a cDNA encoding a human macrophage migration inhibitory factor.

Authors:  W Y Weiser; P A Temple; J S Witek-Giannotti; H G Remold; S C Clark; J R David
Journal:  Proc Natl Acad Sci U S A       Date:  1989-10       Impact factor: 11.205

10.  MIF protein are theta-class glutathione S-transferase homologs.

Authors:  F A Blocki; L B Ellis; L P Wackett
Journal:  Protein Sci       Date:  1993-12       Impact factor: 6.725

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.